Genus plc

As of December 31, 2025, Genus Plc carries a market capitalization of 2.59B, placing it among publicly traded companies globally. Its enterprise value stands at 2.88B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Genus Plc's next confirmed earnings release is scheduled for February 25, 2027.

As of December 31, 2025, Genus Plc has 68.51M shares outstanding.

These figures are as of December 31, 2025.

As of December 31, 2025, Genus Plc maintains a current ratio of 2.25, meaning it holds 2.3x the short-term assets needed to cover near-term liabilities.

These figures cover the twelve months ended December 31, 2025.

As of the close on July 7, 2026, Genus Plc's stock has gained approximately 16.60% over the past 52 weeks.

As of December 31, 2025, Genus Plc holds 58.48M in cash and equivalents against 351.27M in total debt, resulting in a net debt position of 256.28M. Total book value stands at 679.10M, with working capital of 227.85M providing operational flexibility.